SLC2A9, solute carrier family 2 member 9, 56606

N. diseases: 74; N. variants: 389
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C1561643
Disease: Chronic Kidney Diseases
Chronic Kidney Diseases
0.020 GeneticVariation group BEFREE We have recently reported that a polymorphism (rs734553) in a major urate transporter gene (GLUT9) is a strong predictor of incident renal events in stage 2-5 CKD patients implying that life-time exposure to high uric acid levels may be causally implicated in CKD progression. 25435339 2015
CUI: C1561643
Disease: Chronic Kidney Diseases
Chronic Kidney Diseases
0.020 GeneticVariation group BEFREE Known genetic variants in SLC2A9 and ABCG2 were associated with urate and gout in a CKD cohort, with effect sizes for ABCG2 significantly greater in CKD compared to the general population. 30181573 2018
CUI: C0008925
Disease: Cleft Palate
Cleft Palate
0.010 Biomarker disease BEFREE Although further replication studies are critical to confirming these findings, these results illustrate how genetic associations for nonsyndromic CP can be missed if potential GxE interaction is not taken into account, and this study suggest SLC2A9 and WDR1 should be considered as candidate genes for CP. 24516586 2014
CUI: C1837218
Disease: Cleft palate, isolated
Cleft palate, isolated
0.010 Biomarker disease BEFREE Although further replication studies are critical to confirming these findings, these results illustrate how genetic associations for nonsyndromic CP can be missed if potential GxE interaction is not taken into account, and this study suggest SLC2A9 and WDR1 should be considered as candidate genes for CP. 24516586 2014
CUI: C0010054
Disease: Coronary Arteriosclerosis
Coronary Arteriosclerosis
0.020 GeneticVariation disease BEFREE Associations of the uric acid related genetic variants in SLC2A9 and ABCG2 loci with coronary heart disease risk. 25634581 2015
CUI: C0010054
Disease: Coronary Arteriosclerosis
Coronary Arteriosclerosis
0.020 GeneticVariation disease BEFREE Association of common polymorphisms in GLUT9 gene with gout but not with coronary artery disease in a large case-control study. 18398472 2008
CUI: C1956346
Disease: Coronary Artery Disease
Coronary Artery Disease
0.030 AlteredExpression disease BEFREE However, a Mendelian randomization approach using the lead SUA-associated SNPs (SLC2A9 and ABCG2) did not support a causal role of elevated SUA levels for premature CAD. 30305239 2019
CUI: C1956346
Disease: Coronary Artery Disease
Coronary Artery Disease
0.030 GeneticVariation disease LHGDN The aim of the present study was to further elucidate the association of polymorphisms in GLUT9 with gout and coronary artery disease (CAD) or myocardial infarction (MI). 18398472 2008
CUI: C1956346
Disease: Coronary Artery Disease
Coronary Artery Disease
0.030 GeneticVariation disease BEFREE Associations of the uric acid related genetic variants in SLC2A9 and ABCG2 loci with coronary heart disease risk. 25634581 2015
CUI: C1956346
Disease: Coronary Artery Disease
Coronary Artery Disease
0.030 GeneticVariation disease BEFREE The aim of the present study was to further elucidate the association of polymorphisms in GLUT9 with gout and coronary artery disease (CAD) or myocardial infarction (MI). 18398472 2008
CUI: C0010068
Disease: Coronary heart disease
Coronary heart disease
0.020 GeneticVariation disease BEFREE Association of common polymorphisms in GLUT9 gene with gout but not with coronary artery disease in a large case-control study. 18398472 2008
CUI: C0010068
Disease: Coronary heart disease
Coronary heart disease
0.020 GeneticVariation disease BEFREE Association analysis between two uric acid related variants (SNP rs11722228 in SLC2A9 and rs4148152 in ABCG2) and CHD risk was performed by logistic regression model. 25634581 2015
Creatinine measurement, serum (procedure)
0.100 GeneticVariation phenotype GWASCAT Identification of CDC42BPG as a novel susceptibility locus for hyperuricemia in a Japanese population. 29124443 2018
CUI: C1861735
Disease: Dementia, familial Danish
Dementia, familial Danish
0.010 Biomarker disease BEFREE Notably, ITM2B variants linked to familial Danish dementia and retinal dystrophy significantly attenuated the inhibition of GLUT9-mediated urate influx. 31695625 2019
CUI: C0011847
Disease: Diabetes
Diabetes
0.010 GeneticVariation disease BEFREE Results of the present study suggest that the exon 9 of SLC2A9 gene 109C/T polymorphism is not associated with HUA and diabetes in population living in the coastal area of Shandong province, China. 25476142 2015
CUI: C0011849
Disease: Diabetes Mellitus
Diabetes Mellitus
0.030 GeneticVariation group BEFREE Five gout susceptibility loci were identified at the genome-wide significance level (p<5.0×10(-8)), which contained well-known urate transporter genes (ABCG2 and SLC2A9) and additional genes: rs1260326 (p=1.9×10(-12); OR=1.36) of GCKR (a gene for glucose and lipid metabolism), rs2188380 (p=1.6×10(-23); OR=1.75) of MYL2-CUX2 (genes associated with cholesterol and diabetes mellitus) and rs4073582 (p=6.4×10(-9); OR=1.66) of CNIH-2 (a gene for regulation of glutamate signalling). 25646370 2016
CUI: C0011849
Disease: Diabetes Mellitus
Diabetes Mellitus
0.030 GeneticVariation group BEFREE Results of the present study suggest that the exon 9 of SLC2A9 gene 109C/T polymorphism is not associated with HUA and diabetes in population living in the coastal area of Shandong province, China. 25476142 2015
CUI: C0011849
Disease: Diabetes Mellitus
Diabetes Mellitus
0.030 Biomarker group BEFREE Analysis of correlations between the placental expression of glucose transporters GLUT-1, GLUT-4 and GLUT-9 and selected maternal and fetal parameters in pregnancies complicated by diabetes mellitus. 28969476 2019
Diabetes Mellitus, Insulin-Dependent
0.010 AlteredExpression disease BEFREE Morphometric analysis revealed a significant increase in the expression of GLUT-4 and GLUT-9 in insulin-dependent diabetic women (GDMG2 + PGDM) as compared to both, control and GDMG1 groups (p < .05). 27981520 2017
Diabetes Mellitus, Non-Insulin-Dependent
0.040 GeneticVariation disease BEFREE Our study indicated that the uric acid related alleles of SLC2A9 rs11722228, SLC2A9 rs3775948, ABCG2 rs2231142 might affect DKD susceptibility and possibly through non-uric acid pathway in the Chinese people with type 2 diabetes. 26993665 2016
Diabetes Mellitus, Non-Insulin-Dependent
0.040 GeneticVariation disease BEFREE The SLC2A9 mutation increases the risk for T2DM complicated HUA in Chinese population, which suggested that intron variants between two relatively conserved exons could also be associated with diseases. 30087870 2018
Diabetes Mellitus, Non-Insulin-Dependent
0.040 GeneticVariation disease BEFREE Association of an Exon SNP of SLC2A9 Gene with Hyperuricemia Complicated with Type 2 Diabetes Mellitus in the Chinese Male Han Population. 25476142 2015
Diabetes Mellitus, Non-Insulin-Dependent
0.040 Biomarker disease BEFREE More recently, transporters have become important as drug targets (e.g., urate transporter inhibitors as treatment for gout and sodium/glucose cotransporter-2 inhibitors for treating type 2 diabetes). 30270426 2018
CUI: C0495706
Disease: elevated blood glucose level
elevated blood glucose level
0.100 GeneticVariation phenotype GWASDB Human metabolic individuality in biomedical and pharmaceutical research. 21886157 2011
CUI: C0856169
Disease: Endothelial dysfunction
Endothelial dysfunction
0.020 Biomarker phenotype BEFREE These results suggested that the anti-hyperuricaemic and renal protective actions of curcumin might be the result of renal NO-mediated JAK2-STAT3 signalling and TGF-β1 normality, which ameliorated renal endothelial dysfunction to improve renal urate transporter system in this model. 23442673 2012